Medical/Pharmaceuticals
DERMALOG Fever Detection in Operation at Hanover Exhibition Grounds
The spread of coronavirus also affects the event industry. Congresses and trade fairs are postponed or even canceled worldwide for fear of a pandemic. Event organizer UKi Media & Events is using innovative technology from DERMALOG at its present trade fair inHanover to protect its visitors. HAMB...
2020-02-27 21:52
1871
Tessa Therapeutics Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to its CD30 CAR-T Cell Therapy for the Treatment of Relapsed or Refractory CD30-positive Classical Hodgkin Lymphoma
SINGAPORE, Feb. 27, 2020 /PRNewswire/ -- Tessa Therapeutics (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments, today announced that the Company's investigational CD30-directed autologous chimeric antigen receptor T cell (CD30 CAR-T) therapy has been gran...
2020-02-27 20:00
2214
European Medicines Agency accepts submission of GSK's Marketing Authorisation Application for Zejula (niraparib) in first-line maintenance treatment for women with platinum-responsive advanced ovarian cancer
- Submission based on data from the Phase III PRIMA clinical study that demonstrated clinically meaningful outcomes of niraparib maintenance treatment in the first-line setting regardless of biomarker status LONDON, Feb. 27, 2020 /PRNewswire/ -- GlaxoSmithKline plc announced that the European M...
2020-02-27 17:00
1398
Samsung Biologics Confirms 'No Impact' of COVID-19 with Business Continuity Plan in Effect
SONGDO, South Korea, Feb. 24, 2020 /PRNewswire/ -- Samsung Biologics has been monitoring the COVID-19 situation closely since the initial outbreak in late January and taking proactive measures company-wide to ensure a safe working environment and continuous business operations. The company confi...
2020-02-27 15:49
1555
WuXi Diagnostics' integrated testing solution for COVID-19 epidemiological investigation and diagnosis
SHANGHAI, Feb. 27, 2020 /PRNewswire/ -- WuXi Diagnostics has successfully developed a series of COVID-19 detection products, including2019-nCoV IgM Detection kit (Enzyme-linked Immunoassay, ELISA), 2019-nCoV IgM/IgG Detection Kit (Enzyme-linked Immunoassay, ELISA) and 2019-nCoV Nucleic Acid Detec...
2020-02-27 15:47
1919
Country Garden Delivered 100,000 Protective Suits Directly from Sydney to Wuhan to Support Healthcare Workers
FOSHAN, China, Feb. 27, 2020 /PRNewswire/ -- On February 24, 2020, nearly 100,000 protective suits purchased by Country Garden Holdings (HK:2007) through the Guoqiang Foundation were delivered directly fromSydney, Australia to Wuhan via a chartered airplane. Along with supplies and equipment d...
2020-02-27 11:24
9334
Clinical Trial of Ganovo® and Ritonavir Combination Therapy on Novel Coronavirus Pneumonia
HANGZHOU and SHAOXING, China, Feb. 27, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today the advancement in Novel Coronavirus Pneumonia clinical trial of oral Ganovo® and Ritonavir combination therapy, led by Dr. Hongyi CHEN, the director of the Ninth Hospital ofNanchang...
2020-02-27 08:00
3876
New VITROS® XT 3400 Chemistry System from Ortho Clinical Diagnostics Enhances Its VITROS® XT Solutions, Offering Labs Faster, More Accurate Results and Trusted System Reliability to Ensure Better Patient Outcomes
RARITAN, N.J., Feb. 27, 2020 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, today announced the launch and availability of the VITROS® XT 3400 Chemistry System, which completes th...
2020-02-27 01:40
2214
Global Pharmaceutical Contract Manufacturing Organization Market to Reach $102.14 Billion by 2024
Advancements in flexible manufacturing technology to help address new demand in personalized medicine, finds Frost & Sullivan SANTA CLARA, California, Feb. 27, 2020 /PRNewswire/ -- Contract manufacturing organizations (CMOs) are currently transitioning from transactional relationships to strateg...
2020-02-27 01:28
1495
KAHR Medical Raises $18 Million in Private Funding Round
Funds will be used for advancing the Company's next generation immuno-oncology
drug candidates, including lead anti-CD47 product for the treatment of solid
tumors through Phase I/II study in addition to advancing preclinical pipeline
JERUSALEM, Feb. 26, 2020 /PRNewswire/ -- KAHR Medical
2020-02-26 08:30
2827
New Data Confirms Cardiac Dimensions' Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation
Pooled Analysis of Prospective Studies Presented during Late Breaking Trials Session at CRT 2020 KIRKLAND, Washington, Feb. 25, 2020 /PRNewswire/ -- Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatments for functional mitral regurgitation (FMR) in patients ...
2020-02-26 00:50
1166
WuXi Biologics and Vir Biotechnology Announce Collaboration for Global Development of Antibodies to Treat COVID-19
SAN FRANCISCO and SHANGHAI, Feb. 25, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and Vir Biotechnology, Inc. ("Vir") (Nasdaq: VI...
2020-02-25 21:30
2846
Connect Biopharma Enhances its Intellectual Property Estate for CBP-307, a Targeted Therapy with Potential in Multiple Autoimmune Diseases, with Patent Issuances in the United States, EU, Japan and Australia
Novel, next-generation S1P1 agonist currently in Phase 2 clinical development for treatment of inflammatory bowel disease SAN DIEGO and TAICANG, China, Feb. 25, 2020 /PRNewswire/ -- Connect Biopharma, a clinical-stage biopharmaceutical company focused on identifying and developing potent and spe...
2020-02-25 21:00
1053
United Imaging's Emergency Radiology Departments Support Mobile Cabin Hospitals, Facilitate 5G Remote Diagnosis
SHANGHAI, Feb. 25, 2020 /PRNewswire/ -- At the center of the epidemic in Wuhan, many sports centers, exhibition halls, and schools have been turned into mobile cabin hospitals (MCHs) to treat tens of thousands of coronavirus patients with mild symptoms. During the epidemic, fast and accurate CT d...
2020-02-25 21:00
1771
InDex Pharmaceuticals Publishes Mechanism of Action Data for Cobitolimod in Scientific Journal
STOCKHOLM, Feb. 25, 2020 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced the publication of scientific data on the mechanism of action of cobitolimod, the company's lead drug candidate in development for the treatment of moderate to severe ulcerative colitis. The paper, pu...
2020-02-25 15:26
1280
U.S. FDA accepts GSK's sNDA application for Zejula (niraparib) for first-line maintenance treatment for women with platinum-responsive advanced ovarian cancer
- Submission based on data from the Phase III PRIMA clinical study that demonstrated clinically-meaningful outcomes of niraparib maintenance treatment in the first-line setting regardless of biomarker status - The application is being reviewed under the FDA's Real-Time Oncology Review pilot pr...
2020-02-24 22:00
1330
Ascentage Pharma Announces Approval for the Phase Ib/II Clinical Trial of APG-1387 in Combination with Chemotherapy for the Treatment of Advanced Pancreatic Cancer in China
SUZHOU, China and ROCKVILLE, MD., Feb. 24, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the company has receive...
2020-02-24 22:00
2426
Emergency Service from 111 Helps Companies Secure Epidemic Supplies to Open for Business
SHANGHAI, Feb. 24, 2020 /PRNewswire/ -- Businesses across China need to secure epidemic supplies such as face masks and disinfectant to re-open factories and offices. Now they will be able to turn to 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthca...
2020-02-24 16:00
4249
WuXi Biologics Congratulates Immutep on Positive Interim Data for IMP-321
SHANGHAI, Feb. 23, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, congratulates its strategic partner Immutep, a biotechnology comp...
2020-02-24 08:00
6137
Nearly VND 20 billion sponsored by Vingroup for research projects on response to novel coronavirus
HANOI, Vietnam, Feb. 21, 2020 /PRNewswire/ -- 3 units funded by Vingroup
Innovation Foundation (VINIF) include The Company for Vaccine and Biological
Production No.1 (Vabiotech), Pasteur Institute inHo Chi Minh City and Institute
of Preventive Medicine and Public Health.
2020-02-21 10:09
3549
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
6217
